By Carl Elliott
"Just over a decade ago, a new financial opportunity appeared in the field of bioethics. Pharmaceutical and biotechnology companies were giving away money. Some companies had started making contributions to bioethics centers; others paid bioethicists to work as consultants and advisers; still others funded endowed chairs and branded awards.
Many bioethicists welcomed the money, arguing that it would support the good work being done by the field; others thought that it might present a conflict of interest, but one that was manageable as long as the source of the money was disclosed. My own reaction was slightly different. To me, the pharmaceutical industry was the serpent in the garden, and its head would need to be crushed."
Read the entire article here at Chronicle of Higher Ed.
Posts
0 comments:
Post a Comment